Financial

CryoLife, Inc., an implantable biological medical device and tissue processing company, announced today that revenues for the year ended December 31, 2008 increased 11 percent to $105.1 million compared to $94.8 million for the year ended December 31, 2007.

Covidien Ltd. today reported results for the first quarter of fiscal 2009 (October – December 2008). First-quarter net sales rose 6% to $2.5 billion from $2.3 billion a year ago, fueled by very strong growth in Pharmaceutical Products and continued strength in Medical Devices and Medical Supplies.

The Board of Directors of Baxter International Inc. today declared a quarterly dividend of $0.26 per share of Baxter common stock.

BioSyntech, Inc., a biotechnology company developing biotherapeutic thermogels for regenerative medicine, today announced its financial and operational results for the third quarter of fiscal 2009, ended December 31, 2008.

Kinetic Concepts, Inc. today reported fourth quarter and full year 2008 total revenue of $492.5 million and $1.878 billion, respectively, an increase of 14% and 17% from the same respective periods of 2007.

Smith & Nephew on Thursday said it had won a SFr159m ($141m, £109m) cut in the purchase price of Plus Orthopedics, the business which caused it to issue a shock profit warning in May last year.

ArthroCare Corp. announced that it received a waiver today from the Lenders and the Administrative Agent under its Credit Agreement of the event of default relating to the delisting of the Company’s stock.

ArthroCare Corp. announced today that it received a letter from the Nasdaq Listing Qualifications Panel, dated January 14, 2009, stating that the Panel has determined to suspend and delist trading of the Company’s common stock on The Nasdaq Stock Market.

Biomet, Inc. announced today financial results for its second fiscal quarter ended November 30, 2008.

CAMBfix announced that it has received funding to develop CAMBfix technology which allows for the treatment of broken bones without the need for an open operation.

Zimmer Holdings, Inc. announces agreement to acquire Abbott Spine from Abbott for approximately $360 million in cash

A federal jury found that Boston Scientific has infringed three patents owned by Medtronic

Nasdaq Closes Its Review of ArthroCare’s Prior Relationship With DiscoCare Unit